Loading…

Migraine and perimenopause

Abstract Perimenopause and migraine are closely linked. The hormonal instability during the perimenopausal period not only causes vasomotor symptoms and mood disturbances, but also increases migraine incidence. Women do report new onset migraine during this period, but the increased incidence is rep...

Full description

Saved in:

Bibliographic Details
Published in:	Maturitas 2014-08, Vol.78 (4), p.277-280
Main Authors:	Ibrahimi, Khatera, Couturier, Emile G.M, MaassenVanDenBrink, Antoinette
Format:	Article
Language:	English
Subjects:	Biological and medical sciences CGRP Estradiol Estrogen Replacement Therapy - adverse effects Gynecology. Andrology. Obstetrics Hormones - metabolism Humans Internal Medicine Medical sciences Menopause Menstruation Migraine Migraine Disorders - drug therapy Migraine Disorders - etiology Migraine Disorders - metabolism Neurology Obstetrics and Gynecology Perimenopause - metabolism Puberal and climacteric disorders (male and female) Stroke - etiology Vascular diseases and vascular malformations of the nervous system
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by	cdi_FETCH-LOGICAL-c526t-a7bb054270661024affc2bf37b8e41a76f08d434a2f2137133a7aaee998d8ba3
cites	cdi_FETCH-LOGICAL-c526t-a7bb054270661024affc2bf37b8e41a76f08d434a2f2137133a7aaee998d8ba3
container_end_page	280
container_issue	4
container_start_page	277
container_title	Maturitas
container_volume	78
creator	Ibrahimi, Khatera Couturier, Emile G.M MaassenVanDenBrink, Antoinette
description	Abstract Perimenopause and migraine are closely linked. The hormonal instability during the perimenopausal period not only causes vasomotor symptoms and mood disturbances, but also increases migraine incidence. Women do report new onset migraine during this period, but the increased incidence is reported by women with menstrually related migraine (MRM). The hormonal fluctuations can be stabilized with hormone replacement therapy (HRT), while simultaneously improving the migraine in some patients. The increased stroke risk in women with migraine with aura (MA) should be taken into consideration when intending to treat perimenopausal women with migraine with HRT.
doi_str_mv	10.1016/j.maturitas.2014.05.018
format	article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1558517248</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378512214001820</els_id><sourcerecordid>1558517248</sourcerecordid><originalsourceid>FETCH-LOGICAL-c526t-a7bb054270661024affc2bf37b8e41a76f08d434a2f2137133a7aaee998d8ba3</originalsourceid><addsrcrecordid>eNqNkU1v1DAQhq0K1G4Lf4AD9ILUS8KMP2LvBamq-JJa9UDv1sSZIC_ZZLGTSv33eLVLkThxmsvzvjN6Roh3CDUCNh829ZbmJcWZci0BdQ2mBnQnYoXOqkoj4guxAmVdZVDKM3Ge8wYADCh9Ks6kXhttAVfizV38kSiOfEljd7njFLc8TjtaMr8SL3saMr8-zgvx8PnTw83X6vb-y7eb69sqGNnMFdm2BaOlhaZBkJr6Psi2V7Z1rJFs04PrtNIke4nKolJkiZjXa9e5ltSFuDrU7tL0a-E8-23MgYeBRp6W7NEYZ9BK7QpqD2hIU86Je78r91J68gh-78Vv_LMXv_fiwfjipSTfHpcs7Za759wfEQV4fwQoBxr6RGOI-S_nGo1OysJdHzguRh4jJ59D5DFwFxOH2XdT_I9jPv7TEYY4xrL2Jz9x3kxLGotwjz5LD_77_o37L6KGEpegfgN2bJg9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1558517248</pqid></control><display><type>article</type><title>Migraine and perimenopause</title><source>Elsevier</source><creator>Ibrahimi, Khatera ; Couturier, Emile G.M ; MaassenVanDenBrink, Antoinette</creator><creatorcontrib>Ibrahimi, Khatera ; Couturier, Emile G.M ; MaassenVanDenBrink, Antoinette</creatorcontrib><description>Abstract Perimenopause and migraine are closely linked. The hormonal instability during the perimenopausal period not only causes vasomotor symptoms and mood disturbances, but also increases migraine incidence. Women do report new onset migraine during this period, but the increased incidence is reported by women with menstrually related migraine (MRM). The hormonal fluctuations can be stabilized with hormone replacement therapy (HRT), while simultaneously improving the migraine in some patients. The increased stroke risk in women with migraine with aura (MA) should be taken into consideration when intending to treat perimenopausal women with migraine with HRT.</description><identifier>ISSN: 0378-5122</identifier><identifier>EISSN: 1873-4111</identifier><identifier>DOI: 10.1016/j.maturitas.2014.05.018</identifier><identifier>PMID: 24954701</identifier><identifier>CODEN: MATUDK</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Biological and medical sciences ; CGRP ; Estradiol ; Estrogen Replacement Therapy - adverse effects ; Gynecology. Andrology. Obstetrics ; Hormones - metabolism ; Humans ; Internal Medicine ; Medical sciences ; Menopause ; Menstruation ; Migraine ; Migraine Disorders - drug therapy ; Migraine Disorders - etiology ; Migraine Disorders - metabolism ; Neurology ; Obstetrics and Gynecology ; Perimenopause - metabolism ; Puberal and climacteric disorders (male and female) ; Stroke - etiology ; Vascular diseases and vascular malformations of the nervous system</subject><ispartof>Maturitas, 2014-08, Vol.78 (4), p.277-280</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2014 Elsevier Ireland Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c526t-a7bb054270661024affc2bf37b8e41a76f08d434a2f2137133a7aaee998d8ba3</citedby><cites>FETCH-LOGICAL-c526t-a7bb054270661024affc2bf37b8e41a76f08d434a2f2137133a7aaee998d8ba3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28641822$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24954701$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ibrahimi, Khatera</creatorcontrib><creatorcontrib>Couturier, Emile G.M</creatorcontrib><creatorcontrib>MaassenVanDenBrink, Antoinette</creatorcontrib><title>Migraine and perimenopause</title><title>Maturitas</title><addtitle>Maturitas</addtitle><description>Abstract Perimenopause and migraine are closely linked. The hormonal instability during the perimenopausal period not only causes vasomotor symptoms and mood disturbances, but also increases migraine incidence. Women do report new onset migraine during this period, but the increased incidence is reported by women with menstrually related migraine (MRM). The hormonal fluctuations can be stabilized with hormone replacement therapy (HRT), while simultaneously improving the migraine in some patients. The increased stroke risk in women with migraine with aura (MA) should be taken into consideration when intending to treat perimenopausal women with migraine with HRT.</description><subject>Biological and medical sciences</subject><subject>CGRP</subject><subject>Estradiol</subject><subject>Estrogen Replacement Therapy - adverse effects</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Hormones - metabolism</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Medical sciences</subject><subject>Menopause</subject><subject>Menstruation</subject><subject>Migraine</subject><subject>Migraine Disorders - drug therapy</subject><subject>Migraine Disorders - etiology</subject><subject>Migraine Disorders - metabolism</subject><subject>Neurology</subject><subject>Obstetrics and Gynecology</subject><subject>Perimenopause - metabolism</subject><subject>Puberal and climacteric disorders (male and female)</subject><subject>Stroke - etiology</subject><subject>Vascular diseases and vascular malformations of the nervous system</subject><issn>0378-5122</issn><issn>1873-4111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqNkU1v1DAQhq0K1G4Lf4AD9ILUS8KMP2LvBamq-JJa9UDv1sSZIC_ZZLGTSv33eLVLkThxmsvzvjN6Roh3CDUCNh829ZbmJcWZci0BdQ2mBnQnYoXOqkoj4guxAmVdZVDKM3Ge8wYADCh9Ks6kXhttAVfizV38kSiOfEljd7njFLc8TjtaMr8SL3saMr8-zgvx8PnTw83X6vb-y7eb69sqGNnMFdm2BaOlhaZBkJr6Psi2V7Z1rJFs04PrtNIke4nKolJkiZjXa9e5ltSFuDrU7tL0a-E8-23MgYeBRp6W7NEYZ9BK7QpqD2hIU86Je78r91J68gh-78Vv_LMXv_fiwfjipSTfHpcs7Za759wfEQV4fwQoBxr6RGOI-S_nGo1OysJdHzguRh4jJ59D5DFwFxOH2XdT_I9jPv7TEYY4xrL2Jz9x3kxLGotwjz5LD_77_o37L6KGEpegfgN2bJg9</recordid><startdate>20140801</startdate><enddate>20140801</enddate><creator>Ibrahimi, Khatera</creator><creator>Couturier, Emile G.M</creator><creator>MaassenVanDenBrink, Antoinette</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140801</creationdate><title>Migraine and perimenopause</title><author>Ibrahimi, Khatera ; Couturier, Emile G.M ; MaassenVanDenBrink, Antoinette</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c526t-a7bb054270661024affc2bf37b8e41a76f08d434a2f2137133a7aaee998d8ba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Biological and medical sciences</topic><topic>CGRP</topic><topic>Estradiol</topic><topic>Estrogen Replacement Therapy - adverse effects</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Hormones - metabolism</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Medical sciences</topic><topic>Menopause</topic><topic>Menstruation</topic><topic>Migraine</topic><topic>Migraine Disorders - drug therapy</topic><topic>Migraine Disorders - etiology</topic><topic>Migraine Disorders - metabolism</topic><topic>Neurology</topic><topic>Obstetrics and Gynecology</topic><topic>Perimenopause - metabolism</topic><topic>Puberal and climacteric disorders (male and female)</topic><topic>Stroke - etiology</topic><topic>Vascular diseases and vascular malformations of the nervous system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ibrahimi, Khatera</creatorcontrib><creatorcontrib>Couturier, Emile G.M</creatorcontrib><creatorcontrib>MaassenVanDenBrink, Antoinette</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Maturitas</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ibrahimi, Khatera</au><au>Couturier, Emile G.M</au><au>MaassenVanDenBrink, Antoinette</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Migraine and perimenopause</atitle><jtitle>Maturitas</jtitle><addtitle>Maturitas</addtitle><date>2014-08-01</date><risdate>2014</risdate><volume>78</volume><issue>4</issue><spage>277</spage><epage>280</epage><pages>277-280</pages><issn>0378-5122</issn><eissn>1873-4111</eissn><coden>MATUDK</coden><abstract>Abstract Perimenopause and migraine are closely linked. The hormonal instability during the perimenopausal period not only causes vasomotor symptoms and mood disturbances, but also increases migraine incidence. Women do report new onset migraine during this period, but the increased incidence is reported by women with menstrually related migraine (MRM). The hormonal fluctuations can be stabilized with hormone replacement therapy (HRT), while simultaneously improving the migraine in some patients. The increased stroke risk in women with migraine with aura (MA) should be taken into consideration when intending to treat perimenopausal women with migraine with HRT.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>24954701</pmid><doi>10.1016/j.maturitas.2014.05.018</doi><tpages>4</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 0378-5122
ispartof	Maturitas, 2014-08, Vol.78 (4), p.277-280
issn	0378-5122 1873-4111
language	eng
recordid	cdi_proquest_miscellaneous_1558517248
source	Elsevier
subjects	Biological and medical sciences CGRP Estradiol Estrogen Replacement Therapy - adverse effects Gynecology. Andrology. Obstetrics Hormones - metabolism Humans Internal Medicine Medical sciences Menopause Menstruation Migraine Migraine Disorders - drug therapy Migraine Disorders - etiology Migraine Disorders - metabolism Neurology Obstetrics and Gynecology Perimenopause - metabolism Puberal and climacteric disorders (male and female) Stroke - etiology Vascular diseases and vascular malformations of the nervous system
title	Migraine and perimenopause
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T13%3A42%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Migraine%20and%20perimenopause&rft.jtitle=Maturitas&rft.au=Ibrahimi,%20Khatera&rft.date=2014-08-01&rft.volume=78&rft.issue=4&rft.spage=277&rft.epage=280&rft.pages=277-280&rft.issn=0378-5122&rft.eissn=1873-4111&rft.coden=MATUDK&rft_id=info:doi/10.1016/j.maturitas.2014.05.018&rft_dat=%3Cproquest_cross%3E1558517248%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c526t-a7bb054270661024affc2bf37b8e41a76f08d434a2f2137133a7aaee998d8ba3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1558517248&rft_id=info:pmid/24954701&rfr_iscdi=true